<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2022.853608</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nunes</surname>
<given-names>Mariana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1436754"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Patr&#xed;cia M. A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1445798"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coelho</surname>
<given-names>Ricardo</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinto</surname>
<given-names>Carla</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1518052"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Resende</surname>
<given-names>Albina</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1517531"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bousbaa</surname>
<given-names>Hassan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1377260"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Almeida</surname>
<given-names>Gabriela M.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ricardo</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1287535"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup)</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>CESPU, Institute of Research and Advanced Training in Health Sciences and Technologies (IINFACTS)</institution>, <addr-line>Gandra</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>TOXRUN, Toxicology Research Unit, University Institute of Health Sciences, Polytechnic and University Cooperative (CESPU)</institution>, <addr-line>Gandra</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Ovarian Cancer Research, Department of Biomedicine, University Hospital Basel and University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Expression Regulation in Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup)</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Faculty of Medicine from University of Porto (FMUP)</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Sara Ricardo, <email xlink:href="mailto:sricardo@ipatimup.pt">sricardo@ipatimup.pt</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Gynecological Oncology, a section of the journal Frontiers in Oncology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>853608</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Nunes, Silva, Coelho, Pinto, Resende, Bousbaa, Almeida and Ricardo</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Nunes, Silva, Coelho, Pinto, Resende, Bousbaa, Almeida and Ricardo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fonc.2021.752127" ext-link-type="doi">A Corrigendum on <article-title>Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein</article-title> By Nunes M, Silva PMA, Coelho R, Pinto C, Resende A, Bousbaa H, Almeida GM and Ricardo S (2021). <italic>Front. Oncol.</italic>&#xa0;11:752127. doi:<object-id>10.3389/fonc.2021.752127</object-id> </related-article>
<kwd-group>
<kwd>high-grade serous carcinoma</kwd>
<kwd>ovarian cancer</kwd>
<kwd>chemoresistance</kwd>
<kwd>Paclitaxel</kwd>
<kwd>P-glycoprotein</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="230"/>
</counts>
</article-meta>
</front>
<body>
<p>In the original article, we neglected to include the funder. The correct Funding statement appears below. &#x201c;This work was developed at i3S/IPATIMUP, an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and partially supported by Fundac&#x327;&#xe3;o para a Cie&#x302;ncia e a Tecnologia (FCT). This research was supported by European Regional Development Funds (ERDF) funds through the COMPETE 2020&#x2013;Operational Program for Competitiveness and Internationalization (POCI), Portugal 2020, Fundac&#x327;&#xe3;o para a Cie&#x302;ncia e a Tecnologia (FCT)/Ministe&#x301;rio da Cie&#x302;ncia, Tecnologia e Inovac&#x327;&#xe3;o (MCTES), under the project POCI 01-0145-FEDER-029503 (PTDC/MEC-ONC/29503/2017) and CESPU (Cooperativa de Ensino Superior Polit&#xe9;cnico e Universita&#x301;rio) under the project ComeTarget_CESPU_2017 (to HB). MN acknowledges FCT/MCTES and UE for financial support through a PhD fellowship (2020.04720.BD) co-sponsored by Fundo Social Europeu (FSE) through Programa Operacional Regional Norte (Norte 2020).&#x201d;</p>
<p>In the published article, there was an error in affiliation 4. Instead of &#x201c;TOXRUN, Toxicology Research Unit, University Institute of Health Sciences, Advanced Polytechnic and University Cooperative (CESPU), Gandra, Portugal&#x201d; it should be &#x201c;TOXRUN, Toxicology Research Unit, University Institute of Health Sciences, Polytechnic and University Cooperative (CESPU), Gandra, Portugal&#x201d;.</p>
<p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
</article>